APOA1 and hepatocellular carcinoma: Kaplan-Meier analysis showed that the time to recurrence (TTR) of HCC patients with a low serum ApoA-1 level was significantly shorter (median 17.1 months vs. not reached, p=0.001, Figure 1B) and had higher recurrence rates compared with those with a high ApoA-1 level (62.20% vs. 40.85%).